Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CGNX
CGNX logo

CGNX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cognex Corp (CGNX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
66.100
1 Day change
2.05%
52 Week Range
71.900
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Cognex Corp (CGNX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows bullish momentum with strong analyst upgrades, hedge fund buying activity, and a favorable technical setup. Despite the lack of recent news and congress trading data, the company's innovation in AI-enabled solutions and positive price target revisions make it a compelling long-term investment.

Technical Analysis

The stock shows bullish momentum with moving averages in an upward trend (SMA_5 > SMA_20 > SMA_200). The RSI is neutral at 62.237, and the MACD is below 0 but negatively contracting, indicating potential upward movement. The stock closed above the R1 resistance level of 67.085, signaling strength.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios suggest bullish sentiment in the options market.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
0
Buy
9

Positive Catalysts

  • Hedge funds are significantly increasing their positions, with a 2450.31% increase in buying activity last quarter.

  • Analysts have raised price targets significantly, with multiple firms projecting targets in the $75-$80 range.

  • The company is innovating with AI-enabled solutions, expanding its customer base, and diversifying its end markets.

Neutral/Negative Catalysts

  • No significant insider trading activity.

  • The MACD is still below 0, which could indicate some lingering bearish pressure.

  • No recent news or congress trading data to act as additional catalysts.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are bullish on the stock, with several firms upgrading their price targets significantly. JPMorgan, Goldman Sachs, and KeyBanc have set targets of $75-$80, citing strong Q1 results, favorable organic growth outlook, and AI-driven innovations.

Wall Street analysts forecast CGNX stock price to fall
6 Analyst Rating
Wall Street analysts forecast CGNX stock price to fall
3 Buy
2 Hold
1 Sell
Moderate Buy
Current: 64.770
sliders
Low
35
Averages
45.33
High
54
Current: 64.770
sliders
Low
35
Averages
45.33
High
54
JPMorgan
Neutral
to
Overweight
upgrade
$65 -> $75
AI Analysis
2026-05-26
Reason
JPMorgan
Price Target
$65 -> $75
AI Analysis
2026-05-26
upgrade
Neutral
to
Overweight
Reason
JPMorgan upgraded Cognex to Overweight from Neutral with a price target of $75, up from $65. The company \"continues to innovate\" with its AI-enabled solutions that are advancing customer reach and acquisition, the analyst tells investors in a research note. The firm believes Cognex is \"entering a new chapter,\" defined by AI-enabled vision systems and end market diversification. It believes Cognexs ongoing sales model transformation is driving a doubling of the customer base.
DA Davidson
Neutral
maintain
$55 -> $62
2026-05-14
Reason
DA Davidson
Price Target
$55 -> $62
2026-05-14
maintain
Neutral
Reason
DA Davidson raised the firm's price target on Cognex to $62 from $55 and keeps a Neutral rating on the shares after its Q1 results, with the firm boosting its outlook to reflect a more favorable organic growth outlook, mix benefits, and ongoing operating expense leverage. The company's end market outlook has marginally improved, while gross margin achievement exceeded the firm's views and expense leverage continues to track well, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CGNX
Unlock Now

People Also Watch